Project Number ADDF-25 Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Year 2020 View Full Project Details for Phase II Clinical Trial to Evaluate the Safety and Feasibility of Senolytic Therapy in Alzheimer's Disease Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 7. Early-stage Clinical Drug Development (Phase I and II Clinical Trials) t. Other Researcher and Organization Principal Investigator Orr, Miranda Principal Investigator Orr, Miranda Awardee Organization WAKE FOREST UNIVERSITY HEALTH SCIENCES Awardee State North Carolina Contact PI Country United States Project Detail Funding Opportunity Announcement ADDF-Clinical Trial Program FY Overall Cost $3,000,000 Funding Organization Agency/Funding Organization Alzheimer's Drug Discovery Foundation Funding Organization Country United States Program Official ADDF Grants Management
